Fair Pricing of Innovative Medicines: An EHA Position Paper

Fair Pricing of Innovative Medicines: An EHA Position Paper

Bibliographic Details
Main Authors:	Anton Hagenbeek, John Gribben, Ulrich Jäger, Peter Kapitein, Giampaolo Merlini, Maria Piggin, Carin A. Uyl-de Groot, Robin Doeswijk
Format:	Article
Language:	English
Published:	Wiley 2020-10-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/HS9.0000000000000488

Similar Items

Access to Affordable Orphan Medicines in Europe: An EHA Position Paper
by: Giampaolo Merlini, et al.
Published: (2020-10-01)

Affordability of Medicines a Top Priority for EHA: Toward a Fair Pricing Model for Innovative Medicines
by: Anton Hagenbeek, et al.
Published: (2017-12-01)

Personalized Treatment for Hematologic Diseases in Europe: An EHA Position Paper
by: Ulrich Jäger, et al.
Published: (2020-10-01)

Here to Stay: Biosimilars in Hematology
by: John Gribben, et al.
Published: (2019-12-01)

EU-Wide Access to High-quality, Affordable Precision Diagnostics: An EHA Position Paper
by: Elizabeth Macintyre, et al.
Published: (2020-06-01)

The EHA Research Roadmap: Transfusion Medicine
by: Simon J. Stanworth, et al.
Published: (2022-02-01)

The EHA2021 Annual Congress Award Winners: Celebrating Excellence in Hematology
by: John Gribben, et al.
Published: (2021-06-01)

Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks.
by: Toon van der Gronde, et al.
Published: (2017-01-01)

The EHA Research Roadmap: Anemias
by: Achille Iolascon, et al.
Published: (2021-07-01)

The EHA Research Roadmap: Malignant Lymphoid Diseases
by: Martin Dreyling, et al.
Published: (2022-06-01)

The EHA Research Roadmap: normal hematopoiesis
by: Jaffredo, T, et al.
Published: (2021)

The EHA Research Roadmap: Normal Hematopoiesis
by: Thierry Jaffredo, et al.
Published: (2021-12-01)

The EHA Research Roadmap: Malignant Myeloid Diseases
by: Hartmut Döhner, et al.
Published: (2021-09-01)

The EHA Research Roadmap: Platelet Disorders
by: Carlo Balduini, et al.
Published: (2021-07-01)

The EHA Research Roadmap: Infections in Hematology
by: Catherine Cordonnier, et al.
Published: (2021-12-01)

Cost-effectiveness and budget impact of pembrolizumab+axitinib versus sunitinib in patients with advanced clear-cell renal cell carcinoma in the Netherlands
by: Nicolas S. H. Xander, et al.
Published: (2023-06-01)

The Renovated Face of EHA Classical Master Class: A Survey-based Evaluation on Behalf of the EHA Campus Working Group
by: Carmelo Gurnari, et al.
Published: (2022-10-01)

Correction Notice: The EHA Research Roadmap: Anemias
Published: (2021-10-01)

EHA Research Roadmap on Hemoglobinopathies and Thalassemia: An Update
by: Achille Iolascon, et al.
Published: (2019-06-01)

EHA2021 Virtual Congress Abstract Book
Published: (2021-06-01)

Telemedicine networks of EHAS Foundation in Latin America
by: Ignacio ePrieto-Egido, et al.
Published: (2014-10-01)

Electrical and Photodetector Characteristics of Schottky Structures Interlaid with P(EHA) and P(EHA-co-AA) Functional Polymers by the iCVD Method
by: Selçuk Demirezen, et al.
Published: (2023-11-01)

The Use of Next-generation Sequencing in the Diagnosis of Rare Inherited Anaemias: A Joint BSH/EHA Good Practice Paper
by: Noémi B. A. Roy, et al.
Published: (2022-06-01)

The EHA Research Roadmap: Hematopoietic Stem Cells and Allotransplantation
by: Willem Fibbe, et al.
Published: (2022-05-01)

The EHA Research Roadmap: Blood Coagulation and Hemostatic Disorders
by: Sabine Eichinger, et al.
Published: (2021-10-01)

Highlights in Multiple Myeloma Treatment from EHA2021
by: Carmen de Ramon Ortiz
Published: (2021-10-01)

The Price of Fairness
by: Farias, Vivek F., et al.
Published: (2012)

Fair pricing, and pricing paradoxes
by: Barbara Swart
Published: (2016-05-01)

Delivering on the Promise: Innovative Therapies and the Quest for (Real) Patient Benefit
by: Robin Doeswijk
Published: (2019-12-01)

Double Hit Lymphoma Diagnosis and Treatment in Europe—A Cross-Sectional Survey of Clinical Practice by the EHA Lymphoma Working Party (EHA LyG)
by: Igor Aurer, et al.
Published: (2020-12-01)

EHA Endorsement of the European Guidelines for Myelodysplastic Syndromes, MDS-RIGHT
by: Sabine Blum, et al.
Published: (2021-09-01)

The EHA Research Roadmap: Hematopoietic Stem Cell Gene Therapy
by: Luigi Naldini, et al.
Published: (2022-02-01)

EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer
by: Anna Falanga, et al.
Published: (2022-08-01)

EHA Guidance Document The process of CAR-T cell therapy in Europe
Published: (2019-08-01)

The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies
by: Hermann Einsele, et al.
Published: (2021-10-01)

Study on fault diagnosis algorithms of EHA based on CNN-SVM
by: LI Xudong, et al.
Published: (2023-02-01)

An International Survey on Grading, Diagnosis, and Management of Immune Effector Cell-Associated Hematotoxicity (ICAHT) Following CAR T-cell Therapy on Behalf of the EBMT and EHA
by: Kai Rejeski, et al.
Published: (2023-05-01)

Is reference price a fair price or an expected price?
by: K.N. Rajendran
Published: (2009-07-01)

Degradation Identification of an EHA Piston Pump by Analysis of Load-Holding States
by: Yannick Duensing, et al.
Published: (2024-01-01)

Recent Progress in Immunotherapy for RRMM: Updates from EHA 2023 Congress
by: María-Victoria Mateos
Published: (2023-06-01)